LNS: Lithotriptor, Extracorporeal Shock-Wave, Urological
What it covers
An extracorporeal shock wave lithotripter is a device that focuses ultrasonic shock waves into the body to noninvasively fragment urinary calculi within the kidney or ureter. The primary components of the device are a shock wave generator, high voltage generator, control console, imaging/localization system, and patient table. Prior to treatment, the urinary stone is targeted using either an integral or stand-alone localization/imaging system. Shock waves are typically generated using electrostatic spark discharge (spark gap), electromagnetically repelled membranes, or piezoelectric crystal arrays, and focused onto the stone with either a specially designed reflector, dish, or acoustic lens. The shock waves are created under water within the shock wave generator, and are transferred to the patient's body using an appropriate acoustic interface. After the stone has been fragmented by the focused shock waves, the fragments pass out of the body with the patient's urine.
The identification in 21 CFR 876.5990, extracorporeal shock wave lithotripter. FDA gives LNS no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261086 | Break Wave | Sonomotion, Inc. | Apr 29, 2026 | Special |
| K252913 | Break Wave | Sonomotion, Inc. | Jan 12, 2026 | Traditional |
| K242922 | Extracorporeal Shock Wave Lithotripter (U200) | Shenzhen Wikkon Precision Technologies Co., Ltd. | Jun 18, 2025 | Traditional |
| K221903 | Delta III Pro | Dornier Medtech America, Inc. | Feb 22, 2023 | Traditional |
| K213772 | LM-9300 Plus Lithotripter | Lite-Med, Inc. | Jan 19, 2023 | Traditional |
| K201001 | Modulith SLX-F2 | Karl Storz Endoscopy America | Mar 30, 2021 | Traditional |
| K201074 | Delta III Lithotripter | Dornier Medtech America, Inc. | Sep 3, 2020 | Traditional |
| K172084 | Delta III Lithotripter | Dornier Medtech America, Inc. | Aug 8, 2017 | Special |
| K170122 | Delta III Lithotripter | Dornier Medtech America | Jun 28, 2017 | Traditional |
| K151298 | Gemini XXP-HP | Dornier Medtech America | Jul 30, 2015 | Traditional |
Clearances by year
21 LNS 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 75 |
| 2025 | 1 | 267 |
| 2023 | 2 | 325 |
| 2021 | 1 | 348 |
| 2020 | 1 | 134 |
| 2017 | 2 | 98 |
| 2015 | 2 | 133 |
| 2014 | 2 | 434 |
| 2013 | 2 | 42 |
| 2012 | 3 | 111 |
| 2011 | 3 | 307 |
Who submits
13 applicants cleared a LNS device since 2011. 76% of the clearances went to applicants in United States, then Taiwan (14%) and China (10%). By type: Traditional 62%, Special 29% and Abbreviated 10%.
| Applicant | Clearances since 2011 |
|---|---|
| Dornier Medtech America, Inc. | 4 |
| Dornier Medtech America | 3 |
| Lite-Med, Inc. | 3 |
| Sonomotion, Inc. | 2 |
| Comed Medical Systems Co., Ltd. | 1 |
| Direx Systems Corp. | 1 |
| Dornier Medtech Systems | 1 |
| Edap Tms France | 1 |
How FDA classifies it
Class II (special controls) (FDA guidance document: “Guidance for the Content of Premarket Notifications (510(k)'s) for Extracorporeal Shock Wave Lithotripters Indicated for the Fragmentation of Kidney and Ureteral Calculi.”)
From 21 CFR 876.5990. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 876.5990 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LNS clearances declared.
Ask about LNS
Questions about LNS
What is FDA product code LNS?
Product code LNS, “Lithotriptor, Extracorporeal Shock-Wave, Urological” in FDA's classification database, is a Class II device type under 21 CFR 876.5990 (extracorporeal shock wave lithotripter), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 56 clearances under LNS, 21 of them since 2011.
How many 510(k) clearances are there under LNS?
FDA’s 510(k) database listed 56 clearances under LNS as of Oct 29, 2026, 21 of them decided since 2011; the most recent decision was Apr 29, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LNS 510(k)?
For the 3 LNS clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 122 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LNS clearances?
Since 2011: Dornier Medtech America, Inc. (4), Dornier Medtech America (3), Lite-Med, Inc. (3), Sonomotion, Inc. (2) and Comed Medical Systems Co., Ltd. (1). 13 applicants have cleared a LNS device in that time.